Medtronic Unrealized Gains on Investments decreased by 25.0% to $54.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 260.0%, from $15.00M to $54.00M. Over 4 years (FY 2021 to FY 2025), Unrealized Gains on Investments shows a downward trend with a -36.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Rising gains indicate strong performance of the underlying securities, whereas falling gains reflect market headwinds.
This metric tracks the total positive difference between the fair market value and the amortized cost of investment secu...
Commonly reported by all major banks; highly sensitive to interest rate fluctuations.
unrealized_gains_on_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $162.00M | $111.00M | $59.00M | $5.00M | $5.00M | $1.00M | $7.00M | $6.00M | $5.00M | $4.00M | $14.00M | $7.00M | $18.00M | $22.00M | $15.00M | $26.00M | $33.00M | $72.00M | $54.00M |
| QoQ Change | — | -31.5% | -46.8% | -91.5% | +0.0% | -80.0% | +600.0% | -14.3% | -16.7% | -20.0% | +250.0% | -50.0% | +157.1% | +22.2% | -31.8% | +73.3% | +26.9% | +118.2% | -25.0% |
| YoY Change | — | — | — | — | -96.9% | -99.1% | -88.1% | +20.0% | +0.0% | +300.0% | +100.0% | +16.7% | +260.0% | +450.0% | +7.1% | +271.4% | +83.3% | +227.3% | +260.0% |